BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ahmed KT, Almashhrawi AA, Ibdah JA, Tahan V. Is the 25-year hepatitis C marathon coming to an end to declare victory? World J Hepatol 2017; 9(21): 921-929 [PMID: 28824743 DOI: 10.4254/wjh.v9.i21.921]
URL: https://www.wjgnet.com/1948-5182/full/v9/i21/921.htm
Number Citing Articles
1
Kaja Zuwala, Camilla F. Riber, Kaja Borup Løvschall, Anna H.F. Andersen, Lise Sørensen, Paulina Gajda, Martin Tolstrup, Alexander N. Zelikin. Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effectsJournal of Controlled Release 2018; 275: 53 doi: 10.1016/j.jconrel.2018.02.012
2
Zhi-Hong Zhang, Ben-Chun Jiang, Xiao-Hong Liu, Meng-Xuan Zhang, Zhen-Sheng-Nan Li, Guang-Ze Zhu. Interleukin-7 Regulates T Follicular Helper Cell Function in Patients with Chronic Hepatitis CViral Immunology 2018; 31(6): 417 doi: 10.1089/vim.2018.0010
3
Anna Lucia Tornesello, Ulf Reimer, Pavlo Holenya, Tobias Knaute, Francesca Pezzuto, Francesco Izzo, Luigi Buonaguro, Angelo Salomone Megna, Franco Maria Buonaguro, Maria Lina Tornesello. Profiling the HCV Immune Response in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma by Peptide Microarray AnalysisCurrent Medicinal Chemistry 2022; 29(15): 2736 doi: 10.2174/0929867328666211104093718
4
Lorena Vigón, Sonia Vázquez-Morón, Juan Berenguer, Juan González-García, Ma Ángeles Jiménez-Sousa, Josep M. Guardiola, Manuel Crespo, Ignacio de Los Santos, Miguel A. Von Wichmann, Ana Carrero, María Belén Yélamos, Julián Gómez, Salvador Resino, Isidoro Martínez, P. Miralles, J. C. López, F. Parras, B. Padilla, T. Aldamiz-Echevarría, F. Tejerina, C. Díez, L. Pérez-Latorre, C. Fanciulli, I. Gutiérrez, M. Ramírez, S. Carretero, J. M. Bellón, J. Bermejo, V. Hontañón, J. R. Arribas, M. L. Montes, I. Bernardino, J. F. Pascual, F. Zamora, J. M. Peña, F. Arnalich, M. Díaz, P. Domingo, J. Sanz, M. J. Bustinduy, J. A. Iribarren, F. Rodríguez-Arrondo, E Van den Eynde, M. Pérez, E. Ribera, J. L. Casado, F. Dronda, A. Moreno, M. J. Pérez-Elías, M. A. Sanfrutos, S. Moreno, C. Quereda, A. Arranz, E. Casas, J. de Miguel, S. Schroeder, J. Vergas, M. J. Téllez, D. Vinuesa, L. Muñoz, J. Hernández-Quero, A. Ferrer, M. J. Galindo, L. Ortiz, E. Ortega, M. Montero, M. Blanes, S. Cuellar, J. Lacruz, M. Salavert, J. López-Aldeguer, G. Pérez, G. Gaspar, M. Yllescas, P. Crespo, E. Aznar, H. Esteban. Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVRScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-48592-5
5
Ashly Maughan, Onyema Ogbuagu. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infectionExpert Opinion on Drug Metabolism & Toxicology 2018; 14(2): 219 doi: 10.1080/17425255.2018.1421173
6
Vadim A. Shiryaev, Eugene V. Radchenko, Vladimir A. Palyulin, Nikolay S. Zefirov, Nikolay I. Bormotov, Olga A. Serova, Larisa N. Shishkina, Marat R. Baimuratov, Kseniya M. Bormasheva, Yulia A. Gruzd, Elena A. Ivleva, Marina V. Leonova, Anton V. Lukashenko, Dmitry V. Osipov, Vitaliy A. Osyanin, Alexander N. Reznikov, Vera A. Shadrikova, Anastasia E. Sibiryakova, Ilya M. Tkachenko, Yuri N. Klimochkin. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channelsEuropean Journal of Medicinal Chemistry 2018; 158: 214 doi: 10.1016/j.ejmech.2018.08.009